Mealey's (February 14, 2018, 11:18 AM EST) -- PHILADELPHIA — A Pennsylvania state court on Feb. 5 entered a joint stipulation and global dismissal order for a settlement between plaintiffs claiming injury from metoclopramide — the generic version of the prescription heartburn drug Reglan — and Teva Pharmaceuticals USA Inc. and related entities PLIVA Inc. and Richmond Pharmaceuticals Inc. (In Re: Reglan/Metoclopramide Litigation, No. 100010997, Pa. Comm. Pls., Philadelphia Co.)....